Diligent Pharma, a Princeton, NJ-based private vendor qualification and risk management organization, raised $8.27M in Series A funding.
The round was led by FCA Venture Partners with participation from PJC, and GenHenn Capital.
The company intends to use the funds to scale its data and content strategy.
Led by CEO and Founder Patty Leuchten, Diligent Pharma is a private vendor management qualification organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution.
FinSMEs
15/05/2023